Cas:87625-10-3 4-pentylbicyclohexyl-4-one manufacturer & supplier

We serve Chemical Name:4-pentylbicyclohexyl-4-one CAS:87625-10-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-pentylbicyclohexyl-4-one

Chemical Name:4-pentylbicyclohexyl-4-one
CAS.NO:87625-10-3
Synonyms:4′-Pentyl-[1,1′-bi(cyclohexan)]-4-one
Molecular Formula:C17H30O
Molecular Weight:250.41900
HS Code:2914299000

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:0.926
Index of Refraction:
PSA:17.07000
Exact Mass:250.23000
LogP:5.13240

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4′-Pentyl-[1,1′-bi(cyclohexan)]-4-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4′-Pentyl-[1,1′-bi(cyclohexan)]-4-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4′-Pentyl-[1,1′-bi(cyclohexan)]-4-one Use and application,4′-Pentyl-[1,1′-bi(cyclohexan)]-4-one technical grade,usp/ep/jp grade.


Related News: Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder. methanesulfonic 3-(((8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)oxy)-3-oxo-2-(thiophen-3-yl)propanoic anhydride manufacturers BetterUp currently works with more than 370 organizations, of which more than 40 have European headquarters. New partners in the region include bp, which will be onboarding employees this month to support the mental fitness and well-being of the company’s teams. D-Homooestra-1,3,5(10)-trienon-aethylenketal suppliers The role of a trusted contract development and manufacturing organization (CDMO), with long-standing record of regulatory compliance and efficient project management, can help tremendously in reduced time and costs for the early phase development and commercialization of small molecule active pharmaceutical ingredients (APIs) in the pharmaceutical industry, according to experts. copper (II) hematoporphyrin IX vendor & factory.